Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

4,423.08p
   
  • Change Today:
    -26.92p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,500.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 346
  • Market Cap: £230.87m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
31-Dec-23 Interim 6.68 5.24 77.09p 68.00p

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 9.29 6.97 114.04p 32.8 8.2 +4% 73.00p 2.0%
30-Jun-20 10.31 8.23 139.41p 29.8 1.4 +22% 88.00p 2.1%
30-Jun-21 10.93 8.12 129.22p 30.7 n/a -7% 105.00p 2.6%
30-Jun-22 11.72 9.28 147.32p 23.4 1.7 +14% 126.00p 3.7%
30-Jun-23 12.82 10.13 160.63p 24.0 2.7 +9% 152.00p 3.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-24 14.00 11.20 166.20p 26.8 7.7 +4% 161.00p 0.0%
30-Jun-25 15.10 12.10 179.30p 24.8 3.1 +8% 172.00p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 32.80 23.42 28.13 0.98

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Bioventix Market Data

Currency UK Pounds
Share Price 4,423.08p
Change Today -26.92p
% Change -0.61 %
52 Week High 5,060.00
52 Week Low 3,500.00
Volume 346
Shares Issued 5.22m
Market Cap £230.87m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.28% below the market average98.28% below the market average98.28% below the market average98.28% below the market average98.28% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
74.51% above the market average74.51% above the market average74.51% above the market average74.51% above the market average74.51% above the market average
92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average
Income
29.66% below the market average29.66% below the market average29.66% below the market average29.66% below the market average29.66% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
34.04% below the market average34.04% below the market average34.04% below the market average34.04% below the market average34.04% below the market average
27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 11-Apr-24 09-Nov-23
Paid 26-Apr-24 24-Nov-23
Amount 68.00p 90.00p

Trades for 29-Apr-2024

Time Volume / Share Price
09:53 77 @ 4,435.00p
09:46 69 @ 4,463.00p
09:33 2 @ 4,463.00p
09:28 60 @ 4,433.00p
09:21 10 @ 4,400.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page